about
Multicenter assessment of the reproducibility of volumetric radiofrequency-based intravascular ultrasound measurements in coronary lesions that were consecutively stented.Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry - POL-TAVI.Direct transcatheter aortic valve implantation - one-year outcome of a case control study.Mitral and aortic regurgitation following transcatheter aortic valve replacement.Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT)Transcatheter aortic valve replacement in bicuspid aortic valve disease.Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.Intravascular imaging of coronary artery disease: recent progress and future directions.Percutaneous Closure of Post-Infarction Ventricular Septal Defects-An Over Decade-long Experience.Improvement of quality of life following transcatheter aortic valve implantation in the elderly: a multi-centre study based on the Polish national TAVI registry.Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison.Common carotid artery access for transcatheter aortic valve implantation.Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.Inflammatory activity of pericoronary adipose tissue may affect plaque composition in patients with acute coronary syndrome without persistent ST-segment elevation: preliminary results.Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.Successful percutaneous coronary intervention after transcatheter aortic valve implantation with CoreValve bioprosthesis.Prosthetic valve endocarditis after transcatheter CoreValve Evolut R bioprosthesis implantationMicrovascular Obstruction Evaluation Using Cardiovascular Magnetic Resonance (CMR) in ST-Elevated Myocardial Infarction (STEMI) Patients.Tryptase levels in patients after acute coronary syndromes: the potential new marker of an unstable plaque?The impact of renal insufficiency on in-hospital outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventions.Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis--a case report and review of the literature.The long-term prognosis following acute coronary syndromes: a prospective observational study of unselected group treated in the 24/7 cardiac catheterization laboratory at university hospital.Intravascular ultrasound in cocaine-induced myocardial infarction complicated with left coronary artery dissection.Risk factors for adverse outcomes of acute coronary syndrome patients - single center experience in long term follow-up of treated patients.Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.Left ventricular remodelling pattern and its relation to clinical outcomes in patients with severe aortic stenosis treated with transcatheter aortic valve implantation.Augmented reality in left atrial appendage occlusion.Thromboelastography for predicting bleeding in patients with aortic stenosis treated with TAVI.Patient-prosthesis mismatch in patients treated with transcatheter aortic valve implantation - predictors, incidence and impact on clinical efficacy. A preliminary study.Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral--a prospective, randomised clinical trial (OCEAN RACE).Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society….Cost-effectiveness of radial vs. femoral approach in primary percutaneous coronary intervention in STEMI - Randomized, control trial.PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentBaseline platelet reactivity in acute myocardial infarction treated with primary angioplasty--influence on myocardial reperfusion, left ventricular performance, and clinical events.Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI).Bilateral, progressive coronary ostial stenosis following valve sparing aortic root replacement.Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
P50
Q30461333-ABADD6DE-8F8E-4CD9-B79C-5693E772DFA3Q31142296-26F24485-F5B6-4DB5-A027-7137A0694905Q34613431-59A7CD3D-3A58-4CAF-81EA-0D2473A8AF40Q36886667-D3900544-5EFE-4E35-9E3C-FFFE692D5384Q37227540-862FCB5A-EF0D-45A0-AED0-6A093619DACBQ38591597-1E820E7C-FC09-4322-86B2-C526A5F71FBFQ38607422-163CD7A2-8D82-41B4-B18D-F626A2C21BBEQ38611543-75510937-27CE-4ED2-B631-5D3F3AE93D45Q39025586-80837553-FD9E-4401-A081-AB27F5C3FAABQ39160147-F8522CED-96CB-43D6-BF86-8B751F6747C9Q40164383-28CF71F1-5F6D-47F0-8B52-1475E6CCE825Q40720718-219331D1-0012-46BA-8ED5-008BDAF40FEEQ41017084-FBE8A6C7-EA2B-49AC-B4F1-3534FC730C08Q41965783-8399A26B-95F6-4032-9966-826875724861Q41968821-79B22675-677B-479D-BB38-7594266ABAD8Q42118331-D6A49102-794E-422A-BFF6-79588FD4D1DEQ42360028-B12E3C63-E5F0-44DF-9693-560EC5D4C8E7Q43119822-30928BB2-B672-492C-881E-78692058FCC4Q44549571-20A5B646-5E13-4556-A45F-E78F6CF249C0Q44560354-FCA70B92-C72F-4DD8-AF42-7A17930BC341Q46369145-B8F769D2-0138-4CF0-B2AB-36555D40F752Q46867526-4477872F-9584-455D-A1D8-FEAF7C124D73Q47177912-C2837316-656B-49BC-BD11-B6F72B56F805Q47273917-D9BD5A77-D0F4-4871-B05A-D8351EA1FEDCQ47723763-6FDA13C9-249C-4B1B-B662-61435A03357AQ48070996-E26B7C7B-40BF-4133-A3F3-8A8C4CE89714Q48531247-761D70CA-BE1F-4EB7-B3D7-B2551C4FAAE3Q49329568-4D63180C-179E-474C-A88F-B991321B34F7Q49331184-39874122-7998-4C54-81FC-E0FE350E1943Q49383005-C7069E63-F5CD-43FC-B06D-E21A82658740Q49533724-60BDD6E8-E4C9-439D-BC9C-D7A929B6C4DCQ50125079-34B6BB94-36C0-4188-A4A4-4F3A91937695Q50140004-4C3BE1FF-6581-490B-BDEA-4BF1FCD9F149Q50185723-7A7A6B70-1112-466C-AD49-AEC29E5E08F8Q50697336-D717EFE4-A8FA-48A0-925E-36BDA996B3D8Q50936048-9FF435C9-0E6E-47C5-8792-68FABCE2F8A0Q50973495-48189BBC-40D3-43A2-A213-875A519AB7E2Q51022291-D85A78CC-C653-47DB-846D-92014E878B2FQ51068424-3634F92E-897C-4D81-971A-CED17FC7DB6BQ51146102-DCDFE0E6-82A0-4C02-B20B-58149BB53B57
P50
description
researcher
@en
wetenschapper
@nl
name
Janusz Kochman
@en
Janusz Kochman
@nl
type
label
Janusz Kochman
@en
Janusz Kochman
@nl
prefLabel
Janusz Kochman
@en
Janusz Kochman
@nl
P106
P31
P496
0000-0001-8239-8726